Stereotaxis Inc - Asset Resilience Ratio

Latest as of December 2023: 0.00%

Stereotaxis Inc (STXS) has an Asset Resilience Ratio of 0.00% as of December 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read how much debt does Stereotaxis Inc carry for a breakdown of total debt and financial obligations.

Liquid Assets

$0.00
Cash + Short-term Investments

Total Assets

$41.91 Million
All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2003–2023)

This chart shows how Stereotaxis Inc's Asset Resilience Ratio has changed over time. See STXS book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Stereotaxis Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see STXS company net worth.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $0.00 0%
Short-term Investments $0.00 0%
Total Liquid Assets $0.00 0.00%

Asset Resilience Insights

  • Limited Liquidity: Stereotaxis Inc maintains only 0.00% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company maintains a balanced mix of cash and short-term investments.

Stereotaxis Inc Industry Peers by Asset Resilience Ratio

Compare Stereotaxis Inc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Andon Health Co Ltd
SHE:002432
Medical Instruments & Supplies 18.11%
Caina Technology Co. Ltd.
SHE:301122
Medical Instruments & Supplies 19.74%
Jiangsu Apon Medical Technology Co Ltd Class A
SHE:300753
Medical Instruments & Supplies 1.44%
IVF Hartmann Holding AG
SW:VBSN
Medical Instruments & Supplies 52.05%
Guangzhou Jet Bio-Filtration Co Ltd
SHG:688026
Medical Instruments & Supplies 2.86%
Ansell Ltd
AU:ANN
Medical Instruments & Supplies 7.53%
Nanosonics Ltd
AU:NAN
Medical Instruments & Supplies 46.84%
SDI Ltd
AU:SDI
Medical Instruments & Supplies 3.36%

Annual Asset Resilience Ratio for Stereotaxis Inc (2003–2023)

The table below shows the annual Asset Resilience Ratio data for Stereotaxis Inc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2023-12-31 0.00% $0.00 $41.91 Million --
2022-12-31 37.15% $19.84 Million $53.41 Million --
2021-12-31 0.00% $0.00 $60.98 Million --
2012-12-31 3.24% $1.04 Million $32.17 Million -7.73pp
2007-12-31 10.97% $6.63 Million $60.48 Million -20.45pp
2006-12-31 31.42% $21.77 Million $69.29 Million +16.35pp
2005-12-31 15.07% $5.52 Million $36.66 Million -25.30pp
2004-12-31 40.37% $28.74 Million $71.19 Million +26.64pp
2003-12-31 13.73% $5.12 Million $37.32 Million --
pp = percentage points

About Stereotaxis Inc

NYSE MKT:STXS USA Medical Instruments & Supplies
Market Cap
$179.18 Million
Market Cap Rank
#17106 Global
#3929 in USA
Share Price
$1.92
Change (1 day)
+1.05%
52-Week Range
$1.73 - $3.57
All Time High
$10.17
About

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as the Genesis RMN, which enable physicians to complete interventional procedures by providing image-guided delivery of catheters and guidewires thro… Read more